Sattarnezhad N†, Kockum I†, Thomas OG, Liu Y, Ho PP, Barrett AK, A, Wijerante TU, J. Utz PJ, Alfredsson L, Steinman L, Robinson WH, Olsson T†, Lanz TV† Antibody Reactivity against EBNA1 and GlialCAM Differentiates Multiple Sclerosis Patients from Healthy Controls Proc Natl Acad Sci U S A. 2025 Mar 18;122(11):e2424986122. doi: 10.1073/pnas.2424986122. PMID: 40063790
Manouchehrinia A, Fitzgerald KC, Salter A, Marrie RA, Alfredsson L, Bernstein CN, Bolton JM, Cutter G, Fisk JD, Graff LA, Hitchon CA, Hillert J, Kockum I, Lu Y, Lublin FD, McKay K, Olsson T, Patten S, Patki A, Riel H, Shchetynsky K, Stridh P, Tiwari HK, Wolinsky JS, Kowalec K. Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis. Ann Neurol. 2025 Nov;98(5):1057-1069. doi: 10.1002/ana.70020. Epub 2025 Aug 7. PMID: 40772555
Jiang Y, Liu Q, Stridh P, Kockum I, Olsson T, Alfredsson L, Diaz-Gallo LM, Jiang X Multi-omics integration prioritizes potential drug targets for multiple sclerosis Proc Natl Acad Sci U S A. 2025 Jul;122(26):e2425537122. doi: 10.1073/pnas.2425537122. PMID: 40577117
Darvishi S, Donnachie E, Gasperi C, Hapfelmeier A, Hemmer B. Vaccination as a risk factor for pediatric multiple sclerosis: Insights from a retrospective case–control study Mult Scler. 2024 Dec;30(14):1825-1829. doi: 10.1177/13524585241297003. Epub 2024 Nov 14. PMID: 39540267
Petersson M, Jons D, Feresiadou A, Ilinca A, Lundin F, Johansson R, Budzianowska A, Roos AK, Kagstrom V, Gunnarsson M, Sundström P, Klareskog L, Olsson T, Kockum I, Piehl F, Alfredsson L, Brauner S. Nicotine, alcohol consumption and risk of Myasthenia gravis: Results from the Swedish nationwide GEMG study Neurology. 2025 Jul 8;105(1):e213771. doi: 10.1212/WNL.0000000000213771. PMID: 40493875
Jacobs BM, Gasperi C, Kalluri SR, Al-Najjar R, McKeon MO, Else J, Pukaj A, Held F, Sawcer S, Ban M, Hemmer B Single-cell analysis of cerebrospinal fluid reveals common features of neuroinflammation. Cell Rep Med. 2025 Jan 21;6(1):101733. doi: 10.1016/j.xcrm.2024.101733.. PMID: 39708811
Jiang Y, Xiao J, Kockum I, Stridh P, Liu Q, Olsson T, Alfredsson L, Jiang X. Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression. J Neuroinflammation. 2026 Jun 2. doi: 10.1186/s12974-026-03895-z. Online ahead of print. PMID: 42231304
Ingvarsson J, Grut V, Biström M, Berg LP, Butt J, Michels B, Stridh P, Olsson T, Alfredsson L, Kockum I, Waterboer T, Nilsson S, Sundström P Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosis. Clin Transl Immunology. 2026 Apr 16;15(4):e70094. doi: 10.1002/cti2.70094. eCollection 2026. PMID: 42007315
Ebrahimi A, Wiil UK, Olsson T, Liò P, Kockum I, Manouchehrinia A, Kiani NA. A susceptibility network analysis of disease trajectories leading to multiple sclerosis: a nationwide cohort study Mult Scler. 2026 Mar 10:13524585261421480. doi: 10.1177/13524585261421480. Online ahead of print. PMID: 41807266
Corona A, Clarelli F, Pääkkönen K, Harroud A, Shchetynsky K, Zollo A, Mingione A, Sorosina M, Mascia E, Giordano A, Rocca MA, Piehl F, Stridh P, Hemmer B, Goris A, Dubois B, Søndergaard HB, Sellebjerg F, D'alfonso S, Harbo HF, Olsson T, Saarela J, Priori A, Filippi M, Kockum I, Esposito F, Martinelli Boneschi F Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study Mult Scler. 2026 Mar 3:13524585261417130. doi: 10.1177/13524585261417130. Online ahead of print. PMID: 41776383
Thomas OG, Rykaczewska U, Galešić M, van der Burgt RTM, Hallén N, Ferro F, Bronge M, Marti Z, Li Y, Riqué AH, Lin J, Krstic A, Gromadzka A, Szonder AL, Sorini C, Reina-Campos M, Sun T, Rubio Rodríguez-Kirby LA, Dumral Ö, Berglund R, Kakhki MP, Adzemovic MZ, Zeitelhofer M, Akpinar B, Tengvall K, Nilsson OB, Holmgren E, Cucuzza CS, Högelin KA, Gafvelin G, Fink K, Castelo-Branco G, Needhamsen M, Khademi M, Piehl F, Gräslund T, Alfredsson L, Lund H, Uhlén P, Kockum I, Martin R, Jagodic M, Grönlund H, Guerreiro-Cacais AO†, Olsson T† Anoctamin-2-specific T Cells Link Epstein-Barr Virus to Multiple Sclerosis Cell. 2026 Jan 13 189(2):585-602.e38.. doi: 10.1016/j.cell.2025.12.032. PMID: 41534529
Reem Alsulami, Robert Lehmann, Anuj Daga, Sumeer A Khan, Raik Grünberg, Ahmed Abogosh, David Gomez Cabrero, Stefan T Arold, Robert Hoehndorf, Jesper Tegner, Narsis A Kiani; LEP-AD: language embedding of proteins and attention to drugs predicts drug-target interactions . J Cheminform 18, 101 (2026).
Reem Alsulami, Robert Lehmann, Sumeer A Khan, Vincenzo Lagani, Alberto Maillo, David Gomez-Cabrero, Narsis A Kiani, Jesper Tegner; Predicting and interpreting cell-type-specific drug responses in the small-data regime using inductive priors. Nat Mach Intell 8, 461–473 (2026).
Haoling Zhang, Chao-Han Huck Yang, Hector Zenil, Pin-Yu Chen, Yue Shen, Narsis A Kiani, Jesper N Tegnér; Leveraging network motifs to improve artificial neural networks . Nat Commun 16, 11495 (2025)
Reem Alsulami, Robert Lehmann, Sumeer A. Khan, Vincenzo Lagani, Alberto Maillo, David Gomez-Cabrero, Narsis A. Kiani & Jesper Tegner Predicting and interpreting cell-type-specific drug responses in the small-data regime using inductive priors. Nature Machine Intelligence volume 8, pages461–473 (2026)
Haoling Zhang, Chao-Han Huck Yang, Hector Zenil, Pin-Yu Chen, Yue Shen, Narsis A Kiani, Jesper N Tegnér Leveraging network motifs to improve artificial neural networks. Nat Commun. 2025 Dec 13;16(1):11495. PMID: 41390340
Reem Alsulami, Robert Lehmann, Anuj Daga, Sumeer A Khan, Raik Grünberg, Ahmed Abogosh, David Gomez Cabrero, Stefan T Arold Robert Hoehndorf , Jesper Tegner , Narsis A Kiani LEP-AD: language embedding of proteins and attention to drugs predicts drug-target interactions J Cheminform. 2026 Apr 27;18(1):101. PMID: 42046069
Friederike Held, Antonios Bayas, Katharina Christe, Christian Dettmers, Burkhard Domurath, Juliane Ebert, Edeltraud Faßhauer, Peter Flachenecker, Jutta Gärtner, Dzenita Hasanbasic, Christoph Heesen, Harald Hegen, Thomas Henze, Peter Huppke, Veronika Kana, Michael Khalil, Ruth Kirschner-Hermanns, Thomas Korn, Tania Kümpfel, Sabine Lamprecht, Uwe Meier, Gerd Meyer Zu Horste, Mathias Mäurer, Frederike Cosima Oertel , Caroline Pot, Anne-Katrin Pröbstel, Kevin Rostásy, Anke Salmen, Jutta Scheiderbauer, Markus Schmidt, Erwin Stark, Corinna Trebst, Regina Trollmann, Clemens Warnke, Mike P Wattjes, Benedikt Wiestler, Brigitte Wildemann, Uwe Zimmermann, Klaus Gehring, Achim Berthele, Bernhard Hemmer Real-world practices and challenges of radiologically isolated syndrome: results of a cross-sector survey by the DACH MS guidelines group Front Neurol. 2026 Jul 14:17:1822692. doi: 10.3389/fneur.2026.1822692. eCollection 2026. PMID: 42529218
Jakob Maximilian Bader, Christine Makarov, Sabrina Richter, Maximilian Thomas Strauss, Friederike Held, Maria Wahle, Michael Baggio Lorenz , Lara Pöschl , Patricia Skowronek, Marvin Thielert, Achim Berthele, Wen-Feng Zeng, Constantin Ammar, Isabell Bludau, Benjamin Schubert , Fabian J Theis, Christiane Gasperi, Bernhard Hemmer, Matthias Mann Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosis Cell. 2026 Apr 2;189(7):2128-2147.e25. doi: 10.1016/j.cell.2026.01.017. Epub 2026 Feb 25.PMID: 41747728
Roxanne Pretzsch, Sahla El Mahdaoui, Poljanka Johnson, Mafalda Delgado Soares, Kimberly Koerbel, Friederike Held, Albulena Bajrami, Valeria Pozzilli, Matteo Lucchini, Elena Barbuti, Frederik Bartels, Robert Barket, Christian Cordano, Bernhard Hemmer, Alessandro Cagol, Irene Schiavetti, Maria Pia Sormani; ECTRIMS Winter School 2024 study group Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)-A meta-regression of randomized controlled trials Mult Scler. 2026 Mar;32(3):268-278. doi: 10.1177/13524585251407973. Epub 2026 Jan 23.PMID: 41574448